SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Meet 7 Bay Area Scientists Changing the Face of Biotech
Job Trends
Biotechs are Expanding in the Bay Area Again: Bristol-Myers Squibb, Genentech, Gilead, Illumina and Verily and More
August 26, 2016
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Biotech Bay
4 Cheap Biotech Stocks Ready to Fly
August 16, 2016
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
A Gilead and Bristol-Myers Squibb Merger—Let Us Count the Ways
August 12, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Speculation Heats Up on Whether a Spin-Off Could be in Gilead’s Future
August 2, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
A Look at Four Biotech Giants’ Q2 Earnings
July 29, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Why Gilead Should Take a Page Out of Celgene’s Playbook, But Will Have Trouble Doing So
July 27, 2016
 · 
2 min read
Gilead Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency
Deals
A Look at Who Could Buy Gilead and Who Gilead Should Buy
July 21, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Evaluation: 7 Biopharma Companies’ Market Value Based on Pipelines
July 14, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Gilead Used Legal Loopholes to Avoid Paying $10 Billion in Taxes Last Year
July 13, 2016
 · 
2 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Gilead Presents New Data Highlighting Progress In Liver Fibrosis
April 18, 2016
 · 
6 min read
Drug Development
Gilead Announces Multiple Scientific Presentations Demonstrating Broad Utility Of Sofosbuvir-Based Hepatitis C Therapies
April 18, 2016
 · 
9 min read
Drug Development
Gilead’s Hep B Candidate Delivers in Two Late-Stage Studies
April 15, 2016
 · 
4 min read
FDA
FDA Approves Gilead’s Next-Generation HIV Drug Descovy
April 5, 2016
 · 
9 min read
Policy
Gilead Submits New Drug Application To Japan’s Pharmaceutical And Medical Devices Agency For Tenofovir Alafenamide (TAF) For Patients With Chronic Hepatitis B Infection
March 31, 2016
 · 
3 min read
Drug Development
ContraVir’s CMX157 Bests Gilead’s Tenofovir AF (TAF) Against Hep B Virus in Head-to-Head In-Vitro Study
March 29, 2016
 · 
4 min read
Biotech Bay
Gilead Stock May be Cheap Right Now But Investors are Skittish and Doubtful
March 18, 2016
 · 
1 min read
Biotech Bay
Gilead To Present At The Barclays Global Healthcare Conference On Tuesday, March 15
March 11, 2016
 · 
1 min read
Biotech Bay
Gilead Announces Settlement Method For 1.625% Convertible Senior Notes Due 2016
March 7, 2016
 · 
1 min read
Biotech Bay
Gilead To Present At The Cowen and Company 36th Annual Health Care Conference On Monday, March 7
March 7, 2016
 · 
1 min read
Load More